Skip to main content
. 2023 Feb 8;7(21):6532–6539. doi: 10.1182/bloodadvances.2022009381

Table 2.

Cytogenetics of primary and relapsed/refractory ML-DS blasts.

Cytogenetic abnormalities Primary ML-DS (n = 31) Relapsed/refractory ML-DS (n = 31)
Trisomy 8 8 10
Trisomy 21, acquired 6 6
Chromosome 17 Monosomy 17 0 5
del(17p) 0 2
Chromosome 7 Monosomy 7 3 4
i(7)(q10) 3 4
del(7p) 1 1

Among 31 patients who had paired karyotypes available from both time-points, 18 gained abnormalities, 2 lost abnormalities, and 11 showed no change at the time of diagnosis of r/r ML-DS compared to those at the primary diagnosis. The table summarizes the subset of changes present in more than 1 patient.